Compare AbCellera Biologics Inc (ABCL) vs Axogen Inc (AXGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Axogen Inc — how do they compare? AbCellera Biologics Inc trades at $9.25 (market cap $2.99B), while Axogen Inc trades at $48.21 (market cap $2.61B). The key difference: AbCellera Biologics Inc and Axogen Inc are close in size by market cap. Which is the better fit depends on your goals.
| ABCL | AXGN | |
|---|---|---|
Market Cap | $2.99B | $2.61B |
Sector | Health | Technology |
52-Week High | $9.76 | $48.48 |
52-Week Low | $2.78 | $14.16 |
Enterprise Value | $2.58B | $2.52B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Axogen Inc
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →
